← FDA Drug Approvals (Drugs@FDA)

RELPAX

NDA · New Drug Application · Sponsor: UPJOHN · Approved 2002-12-26

Drug application

FDA Application #

NDA021016

Application type

New Drug Application

Brand name

RELPAX

Generic name

ELETRIPTAN HYDROBROMIDE

Active ingredients

ELETRIPTAN HYDROBROMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

UPJOHN

Manufacturer

ROERIG

First approval

2002-12-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown